C12N 2501/10
Growth factors
C12N2501/10 (Growth factors) appears on 3,353 US grants and 6,922 published applications in this corpus.
Search patents in C12N- Granted patents
- 3,353
- Published applications
- 6,922
- Assignees
- 2,238
- Inventors
- 10,686
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 7 | 0 |
| 1994 | 11 | 0 |
| 1995 | 13 | 0 |
| 1996 | 24 | 0 |
| 1997 | 39 | 0 |
| 1998 | 47 | 0 |
| 1999 | 41 | 0 |
| 2000 | 45 | 0 |
| 2001 | 37 | 22 |
| 2002 | 48 | 118 |
| 2003 | 55 | 151 |
| 2004 | 37 | 147 |
| 2005 | 51 | 200 |
| 2006 | 50 | 178 |
| 2007 | 51 | 187 |
| 2008 | 57 | 191 |
| 2009 | 74 | 207 |
| 2010 | 84 | 233 |
| 2011 | 72 | 209 |
| 2012 | 119 | 224 |
| 2013 | 104 | 225 |
| 2014 | 143 | 233 |
| 2015 | 158 | 267 |
| 2016 | 172 | 318 |
| 2017 | 171 | 289 |
| 2018 | 185 | 318 |
| 2019 | 191 | 363 |
| 2020 | 190 | 375 |
| 2021 | 160 | 394 |
| 2022 | 152 | 437 |
| 2023 | 167 | 452 |
| 2024 | 204 | 459 |
| 2025 | 217 | 417 |
| 2026 | 161 | 308 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2501/115Basic fibroblast growth factorIndexing code1,470
- C12N 2501/11Epidermal growth factor [egf]Indexing code975
- C12N 2501/155Bone morphogenic proteins [bmp]Indexing code897
- C12N 2501/15Transforming growth factor betaIndexing code826
- C12N 2501/16ActivinIndexing code506
- C12N 2501/125Stem cell factor [scf], c-kit ligand [kl]Indexing code474
- C12N 2501/105Insulin-like growth factors [igf]Indexing code428
- C12N 2501/119Other fibroblast growth factorsIndexing code369
All 23 subgroupsShow fewer
- C12N 2501/13Nerve growth factor [ngf]Indexing code367
- C12N 2501/165Vascular endothelial growth factor [vegf]Indexing code362
- C12N 2501/12Hepatocyte growth factor [hgf]Indexing code256
- C12N 2501/135Platelet-derived growth factor [pdgf]Indexing code247
- C12N 2501/145Thrombopoietin [tpo]Indexing code228
- C12N 2501/117Keratinocyte growth factorsIndexing code196
- C12N 2501/14Erythropoietin [epo]Indexing code151
- C12N 2501/113Acidic fibroblast growth factorIndexing code121
- C12N 2501/148Transforming growth factor alpha [tgf-a]Indexing code84
- C12N 2501/19Growth and differentiation factors [gdf]Indexing code73
- C12N 2501/195Heregulin, neu differentiation factorIndexing code43
- C12N 2501/17AngiopoietinIndexing code39
- C12N 2501/18Liver cell growth factorIndexing code14
- C12N 2501/175CardiotrophinIndexing code8
- C12N 2501/185OsteoprotegerinIndexing code7
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- High-purity mesenchymal stem cells6 Oct 2026US 12,753,391 B2Purec Co., Ltd.
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
Most cited
By later US patents
- Osteoarthritis cartilage regeneration361US 6,835,377 B2Osiris Therapeutics, Inc. · 2004
- Tissue-derived tissuegenic implants, and methods of fabricating and using same329US 8,883,210 B1Musculoskeletal Transplant Foundation · 2014
- Three-dimensional cell and tissue culture system322US 4,963,489 AMarrow-Tech Incorporated · 1990
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Three-dimensional cartilage cultures289US 5,902,741 AAdvanced Tissue Sciences, Inc. · 1999